IQVIA™ Real-World Insights Bibliography

Patient characteristics and initiation of mineralocorticoid receptor antagonists in patients with chronic kidney disease in routine clinical practice in the US: a retrospective cohort study
Author(s): Blankenburg M1, Fett AK2, Eisenring S3, Haas G2, Gay A4
Affiliations(s): 1. Bayer AG, Market Access, Berlin, Germany; 2. IQVIA Commercial GmbH & Co OHG, Frankfurt/Main, Germany; 3. IQVIA, Basel, Switzerland; 4. Bayer AG, Medical Affairs, Berlin, Germany
Publication(s):  BMC Nephrology 2019;20:171
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Nephrology,
2019
  L:
A:
English
Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Observational study, Retrospective database analysis,
  Add to report
 
 
Estimating glomerular filtration rate in primary care electronic medical record databases in Europe
Author(s): Jouaville SL1, Bizouard G1, Boutmy E1, Keja J2
Affiliations(s): 1QuintilesIMS, Boulogne Billancourt, France, 2QuintilesIMS, Rotterdam, Netherlands
Publication(s):  22nd ISPOR Annual International Meeting, Boston, 2017
Document Type(s): Abstract,
Countries: Germany, UK,
C:
Y:
Diabetes, Methodology, Nephrology,
2017
  L:
A:
English
Clinical setting: Primary care, Retrospective database analysis,
  Add to report
 
 
Cinacalcet Persistence and Adherence in France, Germany, and Italy
Author(s): Dionne M. Hines1, Catherine B. McGuiness1, Rolin L. Wade1, Bruno Fouqueray2, Paul Dluzniewski2
Affiliations(s): 1QuintilesIMS, 2Amgen
Publication(s):  54th ERA-EDTA Congress
Document Type(s): Poster,
Countries: France, Germany, Italy,
C:
Y:
Endocrinology, Nephrology,
2017
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Budget impact of contrast media choice and contrast induced acute kidney injury in high-risk patients undergoing invasive coronary angiography with or without percutaneous coronary intervention from a us hospital perspective.
Author(s): Todoran T, Goldfarb S, Pena CS, Ferrufino CP, Kowal S, De Francesco M, Lamotte M, King A
Affiliations(s): 
Publication(s):  International Society for Pharmacoeconomics and Outcomes Research ? 21st Annual International Meeting, 2016, May, Washington D.C.
Document Type(s): Abstract,
Countries: USA,
C:
Y:
Health economics, Nephrology,
2016
  L:
A:
English
Budget impact,
  Add to report
 
 
Cost-effectiveness of modern mTOR inhibitor based immunosuppression compared to the standard of care after renal transplantation in Germany
Author(s): Jürgensen J1 + 2, Ikenberg R3,Greiner R-A3,Hösel V4
Affiliations(s): 1 Charite Universitätsmedizin, Berlin, Germany 2 Hochschule für Ökonomie und Management, Berlin, Germany 3 IMS Health, Munich, Germany 4 StatsciConsult, Munich, Germany
Publication(s):  European Journal of Health Economics
Document Type(s): Article,
Countries: Germany,
Click here for the abstract
C:
Y:
Nephrology,
2014
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
The need for improved identification and accurate classification of stages 3-5 Chronic Kidney Disease in primary care: retrospective cohort study.
Author(s): Jain P, Calvert M, Cockwell P & McManus RJ
Affiliations(s): University of Birmingham Primary Care Clinical Sciences
Publication(s):  PLoS One. 2014 Aug 12;9(8):e100831. doi: 10.1371/journal.pone.0100831. eCollection 2014
Document Type(s): Article,
Countries: UK,
Click here for the abstract
C:
Y:
Nephrology, Urology,
2014
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
High performance of a risk calculator that includes renal function in predicting mortality of hypertensive patients in clinical application.
Author(s): Ravera M1, Cannavò R1, Noberasco G2, Guasconi A3, Cabib U1, Pieracci L1, Pegoraro V3, Brignoli O2, Cricelli C2, Deferrari G1, Paoletti E1.
Affiliations(s): 1 Division of Nephrology, Dialysis and Transplantation, University of Genoa IRCCS - Azienda Ospedaliera Universitaria San Martino - IST - Genoa 2 Italian College of General Practitioners (SIMG), Florence, 3 Cegedim Strategic Data Medical Research, Milan, Italy.
Publication(s):  J Hypertens. 2014 Jun;32(6):1245-54. doi: 10.1097/HJH.0000000000000177
Document Type(s): Article,
Countries: Italy, UK,
Click here for the abstract
C:
Y:
Cardiovascular disease, Nephrology,
2014
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Renal function, attributes and coagulation treatment in atrial fibrillation (R-FACT Study): retrospective, observational, longitudinal cohort study of renal function and antithrombotic treatment patterns in atrial fibrillation patients with documented eGFR in real-world clinical practices in Germany.
Author(s): D. Wu1, G. Mansoor2, C. Kempf3, M.-S. Schwalm4 andJ. Chin4
Affiliations(s): 1Global Health Outcomes, Merck & Co., Inc., Whitehouse Station, NJ, USA 2Clinical Research, Merck & Co., Inc., Whitehouse Station, NJ, USA 3Cegedim Strategic Data, Paris, France 4Cegedim Strategic Data, Jersey City, NJ, USA
Publication(s):  Int J Clin Pract. 2014 Jun;68(6):714-24
Document Type(s): Article,
Countries: Germany,
Click here for the abstract
C:
Y:
Cardiovascular disease, Nephrology,
2014
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Risk of ESRD and Death in Patients with CKD Not Referred to a Nephrologist: A 7-Year Prospective Study
Author(s): Minutolo R1, Lapi F2, Chiodini P3, Simonetti M2, Bianchini E2, Pecchioli S2, Cricelli I2, Cricelli C4, Piccinocchi G4, Conte G5, De Nicola L5.
Affiliations(s): 1Division of Nephrology and roberto.minutolo@unina2.it. 2Health Search, Italian College of General Practitioners, Florence, Italy; and. 3Medical Statistics Unit, Second University of Naples, Naples, Italy; 4Italian College of General Practitioners, Florence, Italy. 5Division of Nephrology and.
Publication(s):  Clin J Am Soc Nephrol. 2014 Sep 5;9(9):1586-93
Document Type(s): Abstract,
Countries: Italy,
C:
Y:
Methodology, Nephrology,
2014
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Coût du Lupus Systémique (LS) en France des patients adultes avec une maladie active et traitée (étude LUCIE)
Author(s): Amoura Z1, Deligny C2, Pennaforte JL3, Hamidou M4, Blanco P5, Hachulla E6, Pourrat J7, Queyrel V8, Garofano A9, Maurel F9, Levy-Bachelot L10, Boucot I10.
Affiliations(s): 1Service de médecine interne 2, Centre national de référence lupus, hôpital La Pitié-Salpétrière, 47-83, boulevard de l'Hôpital, 75651 Paris cedex 13, France. 2Service de médecine interne et rhumatologie, CHU de Fort-de-France, BP 63297261, Fort-de-France cedex, Martinique. 3Service de médecine interne, hôpital Robert-Debré, rue du Général-Koenig, 51090 Reims, France. 4Service de médecine interne, hôpital Hôtel-Dieu, place Alexis-Ricordeau, 44093 Nantes cedex 1, France. 5Service de médecine interne, hôpital Pèllegrin, place Amélie-Rabat-léon, 33076 Bordeaux cedex, France. 6Service de médecine interne, hôpital Huriez, 1, place de Verdun, 59037 Lille cedex, France. 7Service de néphrologie et immunologie clinique, hôpital Rangueil, 1, avenue du Professeur-Jean-Pouhlès TSA 50032, 31059 Toulouse cedex 9, France. 8Service de médecine interne, hôpital l'Archet, 151, route Saint-Antoine-Ginestière BP 79, 06202 Nice cedex 3, France. 9IMS Real-World Evidence Solutions, Health Economics & Outcomes Research, Tour Ariane, 5-7, place de la Pyramide, 92088 La Défense cedex, France. 10GlaxoSmithKline, 100, route de Versailles, 78163 Marly-le-Roi cedex, France.
Publication(s):  Rev Med Interne. 2014 Nov;35(11):700-8
Document Type(s): Article,
Countries: France,
C:
Y:
Immunology and Vaccination, Nephrology, Rheumatology,
2014
  L:
A:
French
Cost of illness, Observational study, Retrospective Field Study,
  Add to report
 
 
 1 of 5 Next Page Last Page